GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Median PS Value

Celadon Pharmaceuticals (LSE:CEL) Median PS Value : £0.00 (As of Dec. 14, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Celadon Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was £0.002. Celadon Pharmaceuticals's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is £0.00.

As of today (2024-12-14), Celadon Pharmaceuticals's share price is £0.19. Celadon Pharmaceuticals's Median PS Value is £0.00. Therefore, Celadon Pharmaceuticals's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for Celadon Pharmaceuticals's Median PS Value or its related term are showing as below:

LSE:CEL's Price-to-Median-PS-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.9
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

Celadon Pharmaceuticals Median PS Value Historical Data

The historical data trend for Celadon Pharmaceuticals's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Median PS Value Chart

Celadon Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
- - - - -

Celadon Pharmaceuticals Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Median PS Value Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Celadon Pharmaceuticals's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, Celadon Pharmaceuticals's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Celadon Pharmaceuticals's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Celadon Pharmaceuticals's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Celadon Pharmaceuticals's Price-to-Median-PS-Value falls into.



Celadon Pharmaceuticals Median PS Value Calculation

Celadon Pharmaceuticals's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=0.002*0
=0.00

10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Celadon Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was £0.002.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Celadon Pharmaceuticals  (LSE:CEL) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Celadon Pharmaceuticals's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=0.19/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Celadon Pharmaceuticals Median PS Value Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Celadon Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
32-33 Cowcross Street, London, GBR, EC1M 6DF
Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis. It operates only in the UK and has only one geographical area.

Celadon Pharmaceuticals Headlines

No Headlines